MGEMX
Price
$21.71
Change
+$0.34 (+1.59%)
Updated
Jan 30 closing price
Net Assets
513.6M
VEMAX
Price
$37.12
Change
+$0.41 (+1.12%)
Updated
Jan 30 closing price
Net Assets
108.96B
Ad is loading...

MGEMX vs VEMAX

Header iconMGEMX vs VEMAX Comparison
Open Charts MGEMX vs VEMAXBanner chart's image
Morgan Stanley Inst Emerging Mkts I
Price$21.71
Change+$0.34 (+1.59%)
VolumeN/A
Net Assets513.6M
Vanguard Emerging Mkts Stock Idx Adm
Price$37.12
Change+$0.41 (+1.12%)
VolumeN/A
Net Assets108.96B
MGEMX vs VEMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MGEMX vs. VEMAX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGEMX is a StrongBuy and VEMAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 109B vs. MGEMX (514M). VEMAX pays higher dividends than MGEMX: VEMAX (3.43) vs MGEMX (2.37). MGEMX was incepted earlier than VEMAX: MGEMX (32 years) vs VEMAX (19 years). MGEMX is a more actively managed with annual turnover of: 34.00 vs. VEMAX (5.00). VEMAX has a lower initial minimum investment than MGEMX: VEMAX (3000) vs MGEMX (1000000). VEMAX annual gain was more profitable for investors over the last year : 13.85 vs. MGEMX (11.72). VEMAX return over 5 years is better than : 15.47 vs. MGEMX (0.96).
MGEMXVEMAXMGEMX / VEMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years19 years-
Gain YTD0.329-0.163-201%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets514M109B0%
Annual Yield % from dividends2.373.4369%
Returns for 1 year11.7213.8585%
Returns for 3 years-9.43-4.03234%
Returns for 5 years0.9615.476%
Returns for 10 years1.6929.036%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNVS3.660.16
+4.57%
Cineverse Corp
SABR3.390.08
+2.42%
Sabre Corp
PTCT46.150.93
+2.06%
PTC Therapeutics
OPRX5.710.05
+0.88%
OptimizeRx Corp
K81.940.17
+0.21%
Kellanova